Genenta Science (GNTA) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free GNTA Stock Alerts $3.19 -0.13 (-3.92%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Genenta Science Short Interest DataCurrent Short Interest1,900 sharesPrevious Short Interest4,800 sharesChange Vs. Previous Month-60.42%Dollar Volume Sold Short$6,080.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares18,220,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume1,231 sharesAverage Trading Volume3,879 sharesToday's Volume Vs. Average32% Short Selling Genenta Science ? Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNTA Short Interest Over TimeGNTA Days to Cover Over TimeGNTA Percentage of Float Shorted Over Time Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. Genenta Science Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,900 shares $6,080.00 -60.4%N/A0.3 $3.20 4/30/20244,800 shares $14,784.00 +23.1%N/A0.8 $3.08 4/15/20243,900 shares $13,123.50 +30.0%N/A0.7 $3.37 3/31/20243,000 shares $10,500.30 -9.1%N/A0.7 $3.50 3/15/20243,300 shares $12,870.00 -5.7%N/A0.8 $3.90 2/29/20243,500 shares $15,399.65 -5.4%N/A1.2 $4.40 Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,700 shares $14,800.00 +5.7%N/A1.3 $4.00 1/31/20243,500 shares $14,105.00 -5.4%N/A1.3 $4.03 1/15/20243,700 shares $16,465.00 No ChangeN/A1.8 $4.45 12/31/20233,700 shares $18,315.00 -32.7%N/A1.7 $4.95 12/15/20235,500 shares $27,610.00 +14.6%N/A2.5 $5.02 11/30/20234,800 shares $23,760.00 -35.1%N/A2.4 $4.95 11/15/20237,400 shares $38,480.00 +37.0%N/A3.9 $5.20 10/31/20235,400 shares $28,836.00 -25.0%N/A3.2 $5.34 10/15/20237,200 shares $40,248.00 +1.4%N/A3.8 $5.59 9/30/20237,100 shares $36,565.00 +10.9%N/A4.4 $5.15 9/15/20236,400 shares $36,032.00 -1.5%N/A3.6 $5.63 8/31/20236,500 shares $37,700.00 -17.7%N/A3.2 $5.80 8/15/20237,900 shares $43,687.00 +9.7%N/A3.4 $5.53 7/31/20237,200 shares $39,168.00 +50.0%N/A3 $5.44 7/15/20234,800 shares $28,560.00 -14.3%N/A2.2 $5.95 6/30/20235,600 shares $32,984.00 +7.7%N/A2.7 $5.89 6/15/20235,200 shares $29,848.00 +300.0%N/A2.4 $5.74 5/31/20231,300 shares $7,932.73 -23.5%N/A0.5 $6.10 5/15/20231,700 shares $9,537.00 +54.6%N/A0.7 $5.61 4/30/20231,100 shares $6,600.00 +266.7%N/A0.4 $6.00 4/15/2023300 shares $1,890.00 No ChangeN/A0.1 $6.30 3/31/2023300 shares $1,725.00 -40.0%N/A0.1 $5.75 3/15/2023500 shares $3,350.00 -66.7%N/A0.1 $6.70 2/28/20231,500 shares $9,750.00 +114.3%N/A0.3 $6.50 2/15/2023700 shares $4,585.00 -22.2%N/A0.2 $6.55 1/31/2023900 shares $5,526.00 -50.0%N/A0.2 $6.14 1/15/20231,800 shares $11,610.00 -30.8%N/A0.4 $6.45 12/30/20222,600 shares $14,300.00 +116.7%N/A0.6 $5.50 12/15/20221,200 shares $6,780.00 +140.0%N/A0.4 $5.65 11/30/2022500 shares $2,605.00 -80.8%N/A0.2 $5.21 11/15/20222,600 shares $10,816.00 +225.0%N/A1.2 $4.16 10/31/2022800 shares $3,520.00 +33.3%N/A0.4 $4.40 10/15/2022600 shares $2,742.00 -25.0%N/A0.3 $4.57 9/30/2022800 shares $3,983.92 -11.1%N/A0.3 $4.98Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. 9/15/2022900 shares $4,719.33 +125.0%N/A0.3 $5.24 8/31/2022400 shares $2,368.00 -71.4%N/A0.1 $5.92 8/15/20221,400 shares $8,876.00 -12.5%N/A0.4 $6.34 7/31/20221,600 shares $10,512.00 -46.7%N/A0.3 $6.57 7/15/20223,000 shares $20,220.00 No ChangeN/A0.6 $6.74 GNTA Short Interest - Frequently Asked Questions What is Genenta Science's current short interest? Short interest is the volume of Genenta Science shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,900 shares of GNTA short. Learn More on Genenta Science's current short interest. Is Genenta Science's short interest increasing or decreasing? Genenta Science saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,900 shares, a decline of 60.4% from the previous total of 4,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genenta Science's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Genenta Science: Innate Pharma S.A. (0.09%), Genfit S.A. (0.18%), Zura Bio Limited (3.81%), Compugen Ltd. (2.00%), Coherus BioSciences, Inc. (18.98%), Monte Rosa Therapeutics, Inc. (5.98%), Compass Therapeutics, Inc. (1.85%), Invivyd, Inc. (9.17%), Elevation Oncology, Inc. (10.85%), INmune Bio, Inc. (14.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Genenta Science stock? Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genenta Science? A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further. How often is Genenta Science's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Innate Pharma Short Squeeze Genfit Short Squeeze Zura Bio Short Squeeze Compugen Short Squeeze Coherus BioSciences Short Squeeze Monte Rosa Therapeutics Short Squeeze Compass Therapeutics Short Squeeze Invivyd Short Squeeze Elevation Oncology Short Squeeze INmune Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNTA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genenta Science S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.